Drug Trial Radar · NCT02342574
F901318 Multiple Ascending Dose Study
Last checked: Nov 19, 2026Latest source record: Sep 19, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
Feb 2015
Primary completion
Sep 2016
Study completion Sep 2016
Sponsor
- Lead sponsor
- F2G LtdIndustry
- Sponsor type
- Industry
- Collaborators
- Hammersmith Medicines Research
- First posted
- Jan 21, 2015
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Double blind, placebo controlled, parallel group ascending dose study evaluating single and multiple (x8 days) dose levels of F901318 in groups of male healthy subjects with the objective of defining a dosing schedule for phase ll clinical trials. F901318, a novel and potent antifungal agent for the treatment of invasive aspergillosis, will be delivered intravenously in a range of dosing schedules driven by pharmacokinetic evaluation in real time. Safety and tolerability of those schedules will also be assessed.
Conditions
- Invasive Aspergillosis
Interventions
F901318Drug
Administration of active compound
PlaceboDrug
Administration of placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- safety: adverse eventsTime frame: 13 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hammersmith Medicines Research
London, UK, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.